A pre-eminent healthcare and life sciences firm, Dentons is regularly turned to by pharmaceutical companies, biotech and medtech firms, and healthcare providers. Led by Jean-Marc Grosperrin, Julien Le Guyader and Anne-Laure Marcerou, the department continues to advise on M&A transactions, marketing rights, regulatory advice, patent protection and FTO analyses. Grosperrin is regularly sought after by international pharmaceutical groups, while Le Guyader specialises in licensing and market access issues, and Marcerou provides expertise in representing foreign and domestic private equity funds engaging in life sciences investments. Jessica Garestier stands out for her work across the full remit of regulatory matters.
Legal 500 Editorial commentary
Testimonials
Collated independently by Legal 500 research team.
- ‘The team provides excellent legal advice, with a practical approach focused on finding solutions. I would also highlight the immediate availability and responsiveness of the team, and their capacity to advise on complex legal matters from all angles.’
- ‘Anne-Laure Marcerou: outstanding and highly experienced lawyer with a deep knowledge of the healthcare industry, always keen to provide pragmatic solutions.'
- ‘The team is highly specialized in healthcare transactions, having worked with the main players in the industry in France and therefore being very aware of the specificities of each player. This is critical in the negotiation phase of the transaction, as they quickly understand the needs of the counterparty and where they are likely to cave.’
- ‘The Dentons healthcare team is very proactive and responsive. Special mention to Anne-Laure Marcerou, who has consistently led the discussions and the transaction in a very efficient way.’
- ‘The team is distinguished above all by its professionalism, responsiveness, and ability to support clients on complex cases with a rigorous yet pragmatic approach.'
- 'The team's strengths lie in the combination of cutting-edge technical expertise, a genuine understanding of its clients' strategic and operational challenges, and a level of availability that fosters trust on a daily basis.'
Key clients
- Septodont
- Pfizer
- Laboratoires Servier
- Théa Open Innovation
- Laboratoires Coloplast
- H.A.C Pharma
- Gilde Healthcare
- MabSilico
- Eos Imaging
- Sparta
- Sofinnova
- KPS Capital Partners
Work highlights
Advised a long-standing client Laboratoires Servier on preparing the proposed sale of Biogaran and steered the project through vendor due diligence, transaction structuring, and high-level buyer engagement.
Advised Esteve on acquiring exclusive marketing rights to Caprelsa® (vandetanib) across 50+ countries.
Advised Septodont on the acquisition of a 51% majority stake in Laboratorios Inibsa, alongside Acteon, strengthening their position in the dental pharmaceuticals market across Spain, Portugal, and France.
Lawyers
Hall of Fame
The lawyers at the very top of the profession, widely known and respected by peers and clients for their longstanding involvement in market-leading work.
Next Generation Partners
Junior partners with significant recognition from clients and peers in the market and key roles on multiple matters.
Practice head
Jean-Marc Grosperrin; Julien Le Guyader; Anne-Laure Marcerou
Other key lawyers
Jessica Garestier